Cytotoxicity of Metal Based Anticancer Active Complexes and their Targeted Delivery using Nanoparticles

Cytotoxicity of Metal Based Anticancer Active Complexes and their Targeted Delivery using Nanoparticles

Use of metal based anticancer medication began with the clinical approval of cisplatin in 1978. Research led to the development of six platinum based drug candidates which are in use around the world. However there is a great need to develop better treatment strategies. The present work entitled “Cy...

Full description

Bibliographic Details
Main Author: Pramanik, Anup Kumar
Other Authors: Samuelson, A G
Language:en_US
Published: 2018
Subjects:
Anticancer Active Complexes
Platianm Anticancer Drugs
Biometalic Dual Drug
Cytotoxicity
Cytotoxic Agents
Chemotherapy
Platinum(II) Based Drugs
Cancer - Targeted Therapy
Pt(IV)-Cu(II) Bimetallic Dual Drug
Biotinylated PAMAM Dendrimer
Biotinylated Gold Nanoparticles
Binuclear copper(II) bis(thiosemicarbazone) Complexes
Anticancer Agents
Nanoparticles
Inorganic and Physical Chemistry
Online Access:http://hdl.handle.net/2005/3154
http://etd.ncsi.iisc.ernet.in/abstracts/4014/G27893-Abs.pdf

Internet

http://hdl.handle.net/2005/3154
http://etd.ncsi.iisc.ernet.in/abstracts/4014/G27893-Abs.pdf

Similar Items